Summary:
- The FDA has issued new guidance for COVID-19 vaccine manufacturers, requiring them to include protection against the latest Omicron subvariants in their updated booster shots.
- This is an effort to ensure the vaccines remain effective against the evolving virus and provide better protection against the currently dominant Omicron subvariants.
- The updated boosters are expected to be available in the fall, providing an opportunity for people to get a more targeted and effective vaccine ahead of the next potential surge in COVID-19 cases.